P2X1
|
ATP |
|
negative regulation of bone mineralization |
[83] |
P2X2
|
ATP |
|
|
|
P2X3
|
ATP |
|
expressed in human MSCs |
[56] |
P2X4
|
ATP |
|
SNP associates with an increased risk for osteoporosis |
[72] |
P2X5
|
ATP |
|
expressed in human MSCs and osteoblasts |
[56] |
P2X6
|
ATP |
|
upregulated in adipocytes, low expressed in osteoblasts |
[56] |
P2X7
|
ATP |
|
Important role in bone development and homeostasis |
[63, 70, 71, 74–77] |
P2Y1
|
ADP |
Gq/11
|
decreased bone mass in P2Y1−/− mice |
[84] |
P2Y2
|
ATP, ADP |
Gq/11
|
increased bone mass in P2Y2−/− mice |
[84] |
P2Y4
|
UTP |
Gi and Gq/11
|
|
|
P2Y6
|
UDP |
Gq/11
|
decreased bone resorption in P2Y6−/− mice |
[85] |
P2Y11
|
ATP |
Gs and Gq/11
|
|
|
P2Y12
|
ADP |
Gi
|
Important mediator of normal bone maintenance |
[86, 87] |
P2Y13
|
ADP |
Gi
|
decreased bone formation and bone resorption in P2Y13−/− mice |
[84] |
P2Y14
|
UDP-glucose |
Gi
|
|
|